HCC Clinical Trials in Beijing
10 recruitingBeijing, China
Showing 1–10 of 10 trials
Recruiting
Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai Henlius Biotech246 enrolled51 locationsNCT07176650
Recruiting
Phase 1
A Phase I Study of CREPT-618 in Locally Advanced HCC
Hepatocellular Carcinoma (HCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences13 enrolled1 locationNCT07364357
Recruiting
Phase 2
A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC
HCC
GrandPharma (China) Co., Ltd.120 enrolled3 locationsNCT07334483
Recruiting
Phase 2
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital300 enrolled1 locationNCT07157969
Recruiting
Phase 3
Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC
Radiotherapy, AdjuvantHepatocellular Carcinoma (HCC)Immune Checkpoint Inhibitor+2 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences286 enrolled1 locationNCT07186621
Recruiting
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
Hepatocellular Carcinoma (HCC)Microvascular Invasion (MVI)
Chinese Academy of Sciences400 enrolled19 locationsNCT07170345
Recruiting
An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
Hepatocellular Carcinoma (HCC)
Peking Union Medical College Hospital308 enrolled1 locationNCT07101237
Recruiting
Phase 1
Mts105 for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)HCC - Hepatocellular CarcinomaLiver Cancer, Adult+1 more
Shen Lin14 enrolled1 locationNCT06689540
Recruiting
Phase 1
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
HCC
CARsgen Therapeutics Co., Ltd.30 enrolled15 locationsNCT06560827
Recruiting
Comparison of Efficacy in SBRT of Large HCC With or Without TACE
Stereotactic Body Radiation TherapyTranscatheter Arterial ChemoembolizationLarge HCC Patients
Beijing 302 Hospital100 enrolled1 locationNCT04512846